Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10009597HBVENSG00000064989.13protein_codingCALCRLNoNo10203Q16602
TVIS10011300HBVENSG00000064989.13protein_codingCALCRLNoNo10203Q16602
TVIS10041989HBVENSG00000064989.13protein_codingCALCRLNoNo10203Q16602
TVIS30051950HIVENSG00000064989.13protein_codingCALCRLNoNo10203Q16602
TVIS20000113HPVENSG00000064989.13protein_codingCALCRLNoNo10203Q16602
TVIS20001686HPVENSG00000064989.13protein_codingCALCRLNoNo10203Q16602
TVIS44048722HTLV-1ENSG00000064989.13protein_codingCALCRLNoNo10203Q16602
TCGA Plot Options
Drug Information
GeneCALCRL
DrugBank IDDB15328
Drug NameUbrogepant
Target IDBE0009009
UniProt IDQ16602
Regulation Typeantagonist
PubMed IDs33749826
CitationsBlumenfeld AM, Goadsby PJ, Dodick DW, Hutchinson S, Liu C, Finnegan M, Trugman JM, Szegedi A: Efficacy of ubrogepant based on prior exposure and response to triptans: A post hoc analysis. Headache. 2021 Mar;61(3):422-429. doi: 10.1111/head.14089. Epub 2021 Mar 22.
GroupsApproved; Investigational
Direct Classification
SMILESC[C@@H]1[C@@H](C[C@H](NC(=O)C2=CN=C3C[C@]4(CC3=C2)C(=O)NC2=NC=CC=C42)C(=O)N1CC(F)(F)F)C1=CC=CC=C1
Pathways
PharmGKB
ChEMBLCHEMBL2364638